Algeta Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
175
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.7B
Algeta General Information
Description
Developer of novel targeted therapies for patients with cancer, based on its alpha-pharmaceutical platform. The company is focused to extend and improve cancer patient's lives by developing targeted therapies to fulfill unmet medical needs. It's lead product Alpharadin is used for treatment for cancer patients with bone metastases. They are also developing thorium targeted conjugates which are based on conjugating the alpha-emitter thorium-227 to tumor-targeting molecules.
Contact Information
Website
www.algeta.comCorporate Office
- Kaiser-Wilhelm-Allee 1
- 51368 Leverkusen
- Norway
Corporate Office
- Kaiser-Wilhelm-Allee 1
- 51368 Leverkusen
- Norway
Algeta Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 06-Mar-2014 | $2.7B | Completed | Generating Revenue | ||
| 6. PIPE | 15-Feb-2012 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Open Market | 07-Jul-2011 | Completed | Generating Revenue | |||
| 4. PIPE | 18-Feb-2009 | Completed | Generating Revenue | |||
| 3. IPO | 26-Mar-2007 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 01-Sep-2005 | $29M | $29M | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-Jan-2002 | Completed | Startup |
Algeta Signals
Algeta Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abingworth | Venture Capital | Minority | ||
| Advent Life Sciences | Venture Capital | Minority | ||
| Advent Venture Partners | Venture Capital | Minority | ||
| Birk Venture | Venture Capital | Minority | ||
| HealthCap | Venture Capital | Minority |
Algeta FAQs
-
When was Algeta founded?
Algeta was founded in 1997.
-
Where is Algeta headquartered?
Algeta is headquartered in Leverkusen, Norway.
-
What is the size of Algeta?
Algeta has 175 total employees.
-
What industry is Algeta in?
Algeta’s primary industry is Drug Discovery.
-
Is Algeta a private or public company?
Algeta is a Private company.
-
What is the current valuation of Algeta?
The current valuation of Algeta is .
-
What is Algeta’s current revenue?
The current revenue for Algeta is .
-
How much funding has Algeta raised over time?
Algeta has raised $154M.
-
Who are Algeta’s investors?
Abingworth, Advent Life Sciences, Advent Venture Partners, Birk Venture, and HealthCap are 5 of 9 investors who have invested in Algeta.
-
When was Algeta acquired?
Algeta was acquired on 06-Mar-2014.
-
Who acquired Algeta?
Algeta was acquired by Bayer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process